72 related articles for article (PubMed ID: 18594470)
1. Cyclooxygenase-2 expression in primary and metastatic Merkel cell carcinoma.
Joachims Z; Feinmesser R; Purim O; Halpern M; Brenner B; Fenig E; Roizman P; Sulkes J; Feinmesser M
Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):442-6. PubMed ID: 18594470
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2 expression in primary Merkel cell carcinoma.
Koljonen V; Lassus P; Tukiainen E; Ristimäki A; Haglund C; Böhling T
J Cutan Pathol; 2005 Jan; 32(1):55-8. PubMed ID: 15660656
[TBL] [Abstract][Full Text] [Related]
3. c-kit expression in primary and metastatic merkel cell carcinoma.
Feinmesser M; Halpern M; Kaganovsky E; Brenner B; Fenig E; Hodak E; Sulkes J; Okon E
Am J Dermatopathol; 2004 Dec; 26(6):458-62. PubMed ID: 15618926
[TBL] [Abstract][Full Text] [Related]
4. Merkel cell carcinoma: histopathologic and prognostic features according to the immunohistochemical expression of Merkel cell polyomavirus large T antigen correlated with viral load.
Leroux-Kozal V; Lévêque N; Brodard V; Lesage C; Dudez O; Makeieff M; Kanagaratnam L; Diebold MD
Hum Pathol; 2015 Mar; 46(3):443-53. PubMed ID: 25623078
[TBL] [Abstract][Full Text] [Related]
5. Expression of MUC 1 and Ep-CAM in Merkel cell carcinomas: implications for immunotherapy.
Kurzen H; Kaul S; Egner U; Deichmann M; Hartschuh W
Arch Dermatol Res; 2003 Aug; 295(4):146-54. PubMed ID: 12844224
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of EZH2 in Merkel cell carcinoma is associated with disease progression and poorer prognosis.
Harms KL; Chubb H; Zhao L; Fullen DR; Bichakjian CK; Johnson TM; Carskadon S; Palanisamy N; Harms PW
Hum Pathol; 2017 Sep; 67():78-84. PubMed ID: 28739498
[TBL] [Abstract][Full Text] [Related]
7. Reactivity with TdT in Merkel cell carcinoma: a potential diagnostic pitfall.
Buresh CJ; Oliai BR; Miller RT
Am J Clin Pathol; 2008 Jun; 129(6):894-8. PubMed ID: 18480005
[TBL] [Abstract][Full Text] [Related]
8. Merkel cell carcinoma of the eyelid: management and prognosis.
Herbert HM; Sun MT; Selva D; Fernando B; Saleh GM; Beaconsfield M; Collin R; Uddin J; Meligonis G; Leatherbarrow B; Ataullah S; Irion L; McLean CJ; Huilgol SC; Davis G; Sullivan TJ
JAMA Ophthalmol; 2014 Feb; 132(2):197-204. PubMed ID: 24287584
[TBL] [Abstract][Full Text] [Related]
9. Expression of HuR in Merkel cell carcinoma and in normal skin.
Koljonen V; Böhling T; Haglund C; Ristimäki A
J Cutan Pathol; 2008 Jan; 35(1):10-4. PubMed ID: 18095988
[TBL] [Abstract][Full Text] [Related]
10. PAX-8 expression in primary and metastatic Merkel cell carcinoma: an immunohistochemical analysis.
Sangoi AR; Cassarino DS
Am J Dermatopathol; 2013 Jun; 35(4):448-51. PubMed ID: 23612030
[TBL] [Abstract][Full Text] [Related]
11. Increasing tumor thickness is associated with recurrence and poorer survival in patients with Merkel cell carcinoma.
Lim CS; Whalley D; Haydu LE; Murali R; Tippett J; Thompson JF; Hruby G; Scolyer RA
Ann Surg Oncol; 2012 Oct; 19(11):3325-34. PubMed ID: 22820936
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of clinicopathological and immunohistochemical characteristics of Merkel cell carcinoma.
Trenkic Bozinovic M; Krasic D; Katic V; Rancic D; Krstic M; Jocic Djordjevic J; Jovanovic J
J BUON; 2014; 19(2):530-4. PubMed ID: 24965417
[TBL] [Abstract][Full Text] [Related]
13. SOX11 Is an Effective Discriminatory Marker, When Used in Conjunction With CK20 and TTF1, for Merkel Cell Carcinoma: Comparative Analysis of SOX11, CK20, PAX5, and TTF1 Expression in Merkel Cell Carcinoma and Pulmonary Small Cell Carcinoma.
Cho WC; Vanderbeck K; Nagarajan P; Milton DR; Gill P; Wang WL; Curry JL; Torres-Cabala CA; Ivan D; Prieto VG; Aung PP
Arch Pathol Lab Med; 2023 Jul; 147(7):758-766. PubMed ID: 36745184
[TBL] [Abstract][Full Text] [Related]
14. Comparison of CD23 staining patterns in Merkel cell carcinoma and non-cutaneous small cell carcinoma.
Carvalho J; Fullen D; Lowe L; Su L; Ma L
J Cutan Pathol; 2009 Feb; 36(2):206-10. PubMed ID: 18616759
[TBL] [Abstract][Full Text] [Related]
15. P-cadherin expression in Merkel cell carcinomas is associated with prolonged recurrence-free survival.
Vlahova L; Doerflinger Y; Houben R; Becker JC; Schrama D; Weiss C; Goebeler M; Helmbold P; Goerdt S; Peitsch WK
Br J Dermatol; 2012 May; 166(5):1043-52. PubMed ID: 22283194
[TBL] [Abstract][Full Text] [Related]
16. Merkel cell carcinoma: mitoses, expression of Ki-67 and bcl-2 correlate with disease progression.
Vujic I; Marker M; Posch C; Mühlehner D; Monshi B; Breier F; Steiner A; Ortiz-Urda S; Rappersberger K
J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):542-8. PubMed ID: 25088273
[TBL] [Abstract][Full Text] [Related]
17. Tenascin-C expression in Merkel cell carcinoma lymph node metastasis.
Koljonen V; Böhling T; Tukiainen E; Haglund C; Jahkola T
APMIS; 2006 Jan; 114(1):39-42. PubMed ID: 16499659
[TBL] [Abstract][Full Text] [Related]
18. Phosphohistone-H3 (PHH3) is prognostic relevant in Merkel cell carcinomas but Merkel cell polyomavirus is a more powerful prognostic factor than AJCC clinical stage, PHH3, Ki-67 or mitotic indices.
Iwasaki T; Matsushita M; Nonaka D; Kato M; Nagata K; Murakami I; Hayashi K
Pathol Int; 2015 Aug; 65(8):404-9. PubMed ID: 25982855
[TBL] [Abstract][Full Text] [Related]
19. Growth and characterization of a cell line from a human primary neuroendocrine carcinoma of the skin (Merkel cell carcinoma) in culture and as xenograft.
Krasagakis K; Almond-Roesler B; Geilen C; Fimmel S; Krengel S; Chatzaki E; Gravanis A; Orfanos CE
J Cell Physiol; 2001 Jun; 187(3):386-91. PubMed ID: 11319762
[TBL] [Abstract][Full Text] [Related]
20. Potential relevance of cyclooxygenase-2 expression in keratocystic odontogenic tumours - an immunohistochemical study.
Mendes RA; Carvalho JF; van der Waal I
J Oral Pathol Med; 2011 Jul; 40(6):497-503. PubMed ID: 21496105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]